Quantitative Stress Echocardiography to Diagnose Myocardial Ischaemia
NCT ID: NCT03659526
Last Updated: 2018-09-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
390 participants
OBSERVATIONAL
2016-01-21
2021-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The investigators propose an original approach to create a diagnostic software tool that can be used in routine clinical practice. The investigators will extract and compare quantitative data obtained through myocardial velocity imaging and speckle tracking in subjects who undergo dobutamine stress echocardiography.
The data will be analysed using advanced computational mathematics including multiple kernel learning and joint statistics applied to multivariate data across multiple dimensions (including velocity, strain and strain rate traces). This approach will be validated against quantitative coronary arteriography and fractional flow reserve. The results will be displayed as parametric images and placed into a reporting tool. The output will determine the presence and severity of myocardial ischaemia. These new tools will have the capacity for iterative learning so that the precision of the diagnostic conclusions can be continuously refined.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of Echocardiographic Techniques in Diagnosis of Coronary Artery Disease
NCT00001889
Stress Echocardiography Versus Exercise ECG (ExECG) in Women With Chest Pain
NCT02346565
Echocardiography: Value and Accuracy at REst and STress
NCT03674255
Evaluating a New Echocardiography Imaging Procedure for Evaluating Heart Function
NCT00661323
Investigation of Heart Function in Patients With Heart Valve Defects
NCT00001314
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control
Healthy volunteers or if they have had normal invasive or CT coronary arteriography or other functional imaging test
Deformation imaging
Deformation parameters derived using myocardial velocity imaging or speckle tracking
Deformation imaging
Significant coronary disease (diameter stenosis \>50%) has been diagnosed on arteriography or on CT angiography. Fractional flow reserve will be measured as the reference criterion.
Deformation imaging
Deformation parameters derived using myocardial velocity imaging or speckle tracking
High p(CAD)
Intermediate-to-high probability of significant epicardial coronary disease (\>50%).
Deformation imaging
Deformation parameters derived using myocardial velocity imaging or speckle tracking
All comers
Probability of severe disease ranging from 15 to 85%.
Deformation imaging
Deformation parameters derived using myocardial velocity imaging or speckle tracking
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Deformation imaging
Deformation parameters derived using myocardial velocity imaging or speckle tracking
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
89 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universitaire Ziekenhuizen KU Leuven
OTHER
Universitat Pompeu Fabra
OTHER
Hull University Teaching Hospitals NHS Trust
OTHER_GOV
Danderyd Hospital
OTHER
University Hospital of Wales
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Professor Alan G Fraser
Professor of Cardiology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Alan G Fraser
Role: PRINCIPAL_INVESTIGATOR
University Hospital Wales
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UZ Leuven
Leuven, , Belgium
Danderyd Hospital
Stockholm, , Sweden
University Hospital Wales
Cardiff, , United Kingdom
Castle Hill Hospital
Cottingham, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Alan G Fraser
Role: CONTACT
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jens Voigt
Role: primary
Reidar Winter
Role: primary
Alan G Fraser
Role: primary
Imran D Sunderji
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRAS Project ID 136434
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.